MIBG Combination Therapies Show Promise in Neuroblastoma
July 20, 2023
Study shows that combining MIBG therapy with immunotherapy and vorinostat may boost response rates in patients with relapsed neuroblastoma.
The Initiative Will Benefit Innovative Studies and Projects Focused on Improving Children’s Health
Sign up to receive our monthly newsletter, latest news, events and stories delivered right to your inbox.